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Research in the field of polyphenols and
their impact on health and disease has
evolved considerably over the past
decades.1 Not only has there been an
exponential growth in the number of
papers published, but also our under-
standing of these compounds has
evolved from seeing them as simple anti-
oxidants to recognising diverse bioactiv-
ity.2 In accordance, related disciplines,
such as food chemistry, nutrition and
medicine, started considering polyphe-
nols as potential health promoters and
inclusive, therapeutic agents.
Encompassing this evolution, this
thematic issue of Food and Function dis-
plays a collection of papers ranging from
basic studies in food and animal models
and humans, to the latest reviews of epi-
demiological evidence. The articles are
distilled from the symposium titled
‘Polyphenols: the road from plants to
functional foods’ held during the
9th International Conference on
Polyphenols and Health (ICPH). The
issue includes not only presentations
from this symposium, but also work
from select participants of the confer-
ence. Overall, we were fortunate in
obtaining a collection of articles written
by leading active groups in the field of
polyphenols and health.
Investigations on polyphenols today
include, and try to make compatible,
basic chemical characterization and
chemical reactions in food and living
systems, mechanisms of biological rele-
vance, and protection from the develop-
ment and consequences of diseases.
This basic research, helped by the
advent of reliable databases for polyphe-
nol content of foods, has given rise to
large epidemiology studies on fruit and
vegetable consumption indicating
reduced risk of some cancers and cardio-
vascular and metabolic disease with
increased dietary polyphenol intake. As a
result, it has stimulated huge interest in
healthy foods and supplements and a
need to understand the absorption and
metabolism of polyphenolic com-
pounds, their target(s) in biological
systems, and the results of the inter-
actions with those targets.
In this issue, a group of studies
describe the analysis of polyphenols in
foods and dietary supplements, and the
likelihood that they can impact human
health positively (Bussy et al., DOI:
10.1039/C9FO02762A; van Rijs and
Fogliano, DOI: 10.1039/D0FO01158D;
Bondonno et al., DOI: 10.1039/
D0FO01130D; Kan et al., DOI: 10.1039/
D0FO01145B). A second group of papers
are original research in ex vivo and small
animal models that are used as a means
to understand potential mechanisms on
how polyphenols or their metabolites
influence disease. In this group we
include several papers studying the
bioavailability of polyphenols (Pereira-
Caro et al., DOI: 10.1039/D0FO00350F;
Monfoulet et al., DOI: 10.1039/
D0FO00346H; Favari et al., DOI: 10.1039/
D0FO00806K; Anacleto et al., DOI:
10.1039/D0FO01839B) as well as the
functional effects of flavonoids such
as (−)-epicatechin in mouse models
(Hid et al., DOI: 10.1039/D0FO01148G;
Prince et al., DOI: 10.1039/C9FO02234A;
Kang et al., DOI: 10.1039/D0FO00486C)
and one work on the metabolism of poly-
phenols by specific human-gut bacteria
(García-Villalba et al., DOI: 10.1039/
D0FO01649G). This compilation of
research is just a sample of the
extensive fundamental research present
in the literature that gives a strong pre-
clinical base for intervention studies.
Unfortunately, such intervention-based
research is still scarce, pointing out the
need for more human studies, which
have to be based on the use of well-
defined dietary polyphenols and realistic
models applicable to specific disease
conditions. Such human studies are
important, as the bioavailability and
metabolism of polyphenols in humans
may differ from that in animals, and
also because of individual differences in
polyphenol metabolism due to a
number of factors including the gut
microbiome.3
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The collection is completed with key
review articles, including systematic
reviews and meta-analysis of randomised
trials (Cheok et al., DOI: 10.1039/
D0FO00537A; Parmenter et al., DOI:
10.1039/D0FO01118E), and revision of
evidence from large population cohorts
(Sun et al., DOI: 10.1039/C9FO01747J).
Also part of this group of papers, is
work on the use of bioinformatic ana-
lysis of nutrigenomic data obtained in
cells (Ruskovska et al., DOI: 10.1039/
D0FO00701C). Other reviews cover rele-
vant unhealthy conditions, including
studies on cardiovascular risk, metabolic
diseases (diabetes) and neurological
stress (Williamson, DOI: 10.1039/
D0FO01168A; Yamashita et al., DOI:
10.1039/D0FO01092H; John et al., DOI:
10.1039/D0FO01133A; Sakakibara and
Shimoi, DOI: 10.1039/D0FO01129K).
Clearly, a lot has been done in terms
of polyphenols and health, but also a lot
remains to be done. Today, based on the
presented data and on the extensive lit-
erature available, we ‘perceive’ that poly-
phenols have a positive effect on human
health. However, we need more defini-
tive human data before it is possible to
give precise answers on which com-
pound, in what amount, and for what
disease, the consumption of that poly-
phenol is of benefit. As mentioned,
more human intervention studies
(chronic or long term if possible) are
needed, guided by the importance of the
disease condition, and coupled with
mechanistic studies based on realistic
concentrations of polyphenols or their
metabolites in the organ/system under
study. The concretion of this complex
matrix of research, is definitively necess-
ary for the advance our understanding
in this field.
Finally, we would like to recognize
the trigger of this issue: the 9th ICPH.
Held in Kobe, Japan, from November 28
to December 1, 2019, this conference
was lead by Professors Hitoshi Ashida
(Kobe University) and Kayoko Shimoi
(University of Shizuoka) as joint
Presidents. They put together an exciting
programme that developed into a superb
meeting, in terms of scientific quality
and global attendance. ICPHs are key
meetings gathering leading scientists
and showing the latest developments in
the research relating to polyphenols and
health. The coming 10th ICPH will be
held in London at the end of 2021, and
will be organised by Professor Jeremy
Spencer (University of Reading). We
hope it will be a place for demonstrating
new insights aimed to solidify the
association between polyphenols and
human well-being.
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